OMCL - Omnicell, Inc. -  [ ]

Ticker Details
Omnicell, Inc.
Omnicell Inc provides automation and business analytics software solutions for patient-centric medication and supplies management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing.
IPO Date: August 7, 2001
Sector: Healthcare
Industry: Health Care Technology
Market Cap: $1.61B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.62 | 1.68%
Avg Daily Range (30 D): $0.66 | 1.81%
Avg Daily Range (90 D): $0.76 | 1.86%
Institutional Daily Volume
Avg Daily Volume: .29M
Avg Daily Volume (30 D): .4M
Avg Daily Volume (90 D): .48M
Trade Size
Avg Trade Size (Sh.): 84
Avg Trade Size (Sh.) (30 D): 41
Avg Trade Size (Sh.) (90 D): 44
Institutional Trades
Total Institutional Trades: 6,337
Avg Institutional Trade: $2.62M
Avg Institutional Trade (30 D): $2.37M
Avg Institutional Trade (90 D): $2.31M
Avg Institutional Trade Volume: .05M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $3.35M
Avg Closing Trade (30 D): $3.75M
Avg Closing Trade (90 D): $3.91M
Avg Closing Volume: 55.84K
 
News
Apr 9, 2026 @ 8:57 AM
Robotic Pharmacy Prescription Market Research and ...
Source: Researchandmarkets.Com
Jan 5, 2026 @ 8:33 PM
Omnicell Executive Trims Holdings in $244,000 Sale...
Source: Sara Appino
Aug 26, 2025 @ 11:00 AM
Evoke Pharma and EVERSANA Expand GIMOTI® Access...
Source: Daniel Kontoh-Boateng
Jul 21, 2025 @ 2:00 PM
Pharmacy Automation Market Surges with 10.12% CAGR...
Source: Towards Healthcare
Nov 3, 2024 @ 2:28 PM
Apple Satellite Connectivity Provider Globalstar A...
Source: Lekha Gupta
Financials
  TTM Q4 2025 FY 2025
Basic EPS $.04 $-.05 $.04
Diluted EPS $.04 $-.05 $.04
Revenue $1.18B $313.98M $1.18B
Gross Profit $503.44M $130.33M $503.44M
Net Income / Loss $2.05M $-2.03M $2.05M
Operating Income / Loss $5.16M $.42M $5.16M
Cost of Revenue $681.4M $183.66M $681.4M
Net Cash Flow $-147.58M $25.58M $-147.58M
PE Ratio 860.00